These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 34537164)
21. Limb-onset amyotrophic lateral sclerosis patients visiting orthopedist show a longer time-to-diagnosis since symptom onset. Kano O; Iwamoto K; Ito H; Kawase Y; Cridebring D; Ikeda K; Iwasaki Y BMC Neurol; 2013 Feb; 13():19. PubMed ID: 23394455 [TBL] [Abstract][Full Text] [Related]
22. Natural history and clinical features of sporadic amyotrophic lateral sclerosis in China. Chen L; Zhang B; Chen R; Tang L; Liu R; Yang Y; Yang Y; Liu X; Ye S; Zhan S; Fan D J Neurol Neurosurg Psychiatry; 2015 Oct; 86(10):1075-81. PubMed ID: 26124198 [TBL] [Abstract][Full Text] [Related]
23. ISIS Survey: an international study on the diagnostic process and its implications in amyotrophic lateral sclerosis. Chiò A J Neurol; 1999 Nov; 246 Suppl 3():III1-5. PubMed ID: 10631652 [TBL] [Abstract][Full Text] [Related]
24. The path to diagnosis in ALS: delay, referrals, alternate diagnoses, and clinical progression. Sennfält S; Kläppe U; Thams S; Samuelsson K; Press R; Fang F; Ingre C Amyotroph Lateral Scler Frontotemporal Degener; 2023 Feb; 24(1-2):45-53. PubMed ID: 35343340 [No Abstract] [Full Text] [Related]
25. Evaluation of the application of the European guidelines for the diagnosis and clinical care of amyotrophic lateral sclerosis (ALS) patients in six French ALS centres. Marin B; Beghi E; Vial C; Bernard E; Lautrette G; Clavelou P; Guy N; Lemasson G; Debruxelles S; Cintas P; Antoine JC; Camdessanche JP; Logroscino G; Preux PM; Couratier P; Eur J Neurol; 2016 Apr; 23(4):787-95. PubMed ID: 26833536 [TBL] [Abstract][Full Text] [Related]
27. Diagnostic problems and delay of diagnosis in amyotrophic lateral sclerosis. Kraemer M; Buerger M; Berlit P Clin Neurol Neurosurg; 2010 Feb; 112(2):103-5. PubMed ID: 19931253 [TBL] [Abstract][Full Text] [Related]
29. [Amyotrophic lateral sclerosis (ALS) from the perspective of Primary Care. Epidemiology and clinical-care characteristics]. Castro-Rodríguez E; Azagra R; Gómez-Batiste X; Povedano M Aten Primaria; 2021 Dec; 53(10):102158. PubMed ID: 34509895 [TBL] [Abstract][Full Text] [Related]
30. Effect of neurofilament analysis on the diagnostic delay in amyotrophic lateral sclerosis. De Schaepdryver M; Masrori P; Van Damme P; Poesen K CNS Neurosci Ther; 2023 Jan; 29(1):70-77. PubMed ID: 36047371 [TBL] [Abstract][Full Text] [Related]
32. A Brazilian multicentre study on the clinical and epidemiological profiles of 1116 patients with amyotrophic lateral sclerosis and its phenotypic variants. Marques Couto C; de Melo Queiroz E; Nogueira R; Pires Duarte Küsel AP; J M Nascimento O Amyotroph Lateral Scler Frontotemporal Degener; 2022 Aug; 23(5-6):353-362. PubMed ID: 34823435 [No Abstract] [Full Text] [Related]
33. Predictors of delay in the diagnosis and clinical trial entry of amyotrophic lateral sclerosis patients: a population-based study. Zoccolella S; Beghi E; Palagano G; Fraddosio A; Samarelli V; Lamberti P; Lepore V; Serlenga L; Logroscino G; J Neurol Sci; 2006 Dec; 250(1-2):45-9. PubMed ID: 16920152 [TBL] [Abstract][Full Text] [Related]
34. Analysis of clinical and electrophysiological characteristics of 150 patients with amyotrophic lateral sclerosis in China. Liu J; Zhang X; Ding X; Song M; Sui K Neurol Sci; 2019 Feb; 40(2):363-369. PubMed ID: 30467636 [TBL] [Abstract][Full Text] [Related]
35. A retrospective study of the clinical phenotype and predictors of survival in non-Caucasian Hispanic patients with amyotrophic lateral sclerosis. Sánchez-Martínez CM; Choreño-Parra JA; Nuñez-Orozco L; Placencia-Álvarez N; Alvis-Castaño LM; Guadarrama-Ortiz P BMC Neurol; 2019 Oct; 19(1):261. PubMed ID: 31664949 [TBL] [Abstract][Full Text] [Related]
36. [Survival in amyotrophic lateral sclerosis]. Alcaz S; Jarebinski M; Pekmezović T; Marinković Z; Apostolski S Srp Arh Celok Lek; 1997; 125(1-2):19-23. PubMed ID: 17974351 [TBL] [Abstract][Full Text] [Related]
37. Relevance of the pyramidal syndrome in amyotrophic lateral sclerosis. Álvarez N; Díez L; Avellaneda C; Serra M; Rubio MÁ Neurologia (Engl Ed); 2018; 33(1):8-12. PubMed ID: 27340020 [TBL] [Abstract][Full Text] [Related]
38. Measurement of cystatin C levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Ren Y; Zhu W; Cui F; Yang F; Chen Z; Ling L; Huang X Int J Clin Exp Pathol; 2015; 8(5):5419-26. PubMed ID: 26191245 [TBL] [Abstract][Full Text] [Related]
39. Serum Cystatin C is a potential biomarker for predicting amyotrophic lateral sclerosis survival. Zhu Y; Huo Y; Bai J; Li M; Wang H; Wang J; Huang X Neurol Sci; 2024 Jan; 45(1):197-201. PubMed ID: 37548757 [TBL] [Abstract][Full Text] [Related]